CLINICAL CANCER RESEARCH Journal
Overview
publication venue for
- CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. 29:3484-3497. 2023
- Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally for Advanced Head and Neck Squamous Cell Carcinoma. 28:1345-1352. 2022
- Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. 23:311-319. 2017
- A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.. 21:1019-27. 2015
- Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.. 21:2278-88. 2015
- CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.. 18:2039-47. 2012
- CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.. 16:6122-31. 2010
- Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue. 15:5541-5551. 2009
- Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.. 14:5610-8. 2008
- Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.. 13:6681-8. 2007
- Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. 11:1073-1085. 2005
- Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.. 11:1073-85. 2005
- Serum Protein Profiles to Identify Head and Neck Cancer. 10:1625-1632. 2004
- Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.. 8:2541-52. 2002
Identity
International Standard Serial Number (ISSN)
- 1078-0432
Electronic International Standard Serial Number (EISSN)
- 1557-3265